Australia’s Fertility Sector Faces Major Takeover Bid
Australia’s second-largest fertility services provider, Monash IVF, is currently in the spotlight after receiving a takeover offer that could significantly boost its valuation. The company has approximately one week to consider the proposal, which values the group at nearly $100 million more than its current market value.
Shares in Monash IVF saw a sharp increase on Monday, rising by almost 16 per cent to 77 cents. This surge came after the bid was made public. The potential buyers are offering 90 cents per share, a figure that is well above the stock’s closing price on Friday, which stood at 66.5 cents. At that time, the company had a market value of around $260 million.
This is not the first time that investment vehicle WHSP Holdings and private equity group Genesis Capital have shown interest in Monash IVF. In November, the two entities had previously pursued the company when it was facing challenges due to an embryo implant scandal. A patient at a laboratory in Melbourne’s southeast was mistakenly implanted with her own embryo instead of one from her partner, as requested. The company later attributed the error to human mistakes and limitations in its IT systems.
At that time, WHSP and Genesis offered 80 cents per share for all the stock in Monash IVF. The company has struggled to trade above 90 cents for over 12 months, with its most recent high reaching $1.23 in February 2025. However, it has previously traded close to $1.50.
On Monday afternoon, the stock fell slightly from its intraday high, settling at 76 cents, which represents a gain of just over 14 per cent. This valuation places the company at about $350 million. The bidders, who currently hold 19.6 per cent of Monash IVF’s shares, have stated that their offer is valid until April 21. They also seek exclusive access to the company’s financial records and the unanimous recommendation of the board.
Monash IVF described the approach as unsolicited, conditional, and non-binding. In a statement, the company said, “The Monash IVF board is assessing the proposal, including obtaining advice from its financial and legal advisors.” It added, “It should be noted that there is no certainty that the discussions with the consortium will result in any transaction.”
In April 2025, Monash IVF revealed another incident involving the incorrect implantation of a patient’s embryo at a Brisbane facility in 2023. This mistake led to a woman giving birth to a stranger’s baby. Both this incident and the Victorian case prompted an independent review led by prominent barrister Fiona McLeod. Although the review has been completed, its full details have not yet been disclosed.
According to the latest data from the Australian and New Zealand Assisted Reproduction database, approximately 20,000 babies conceived through IVF are born in Australia each year. This accounts for roughly one in 18 children, with the rate increasing to one in 10 for those born to mothers aged 35 and older.
